Cytek Biosciences (CTKB) Share-based Compensation Growth (1y) (2021 - 2025)
Cytek Biosciences (CTKB) Share-based Compensation Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -30.44% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 59.09% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytek Biosciences | 586.89 Mn | 521.19 Mn | 21.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 412.23% |
| Sep 30, 2025 | 244.41% |
| Jun 30, 2025 | 220.39% |
| Mar 31, 2025 | 17.55% |
| Dec 31, 2024 | -95.11% |
| Sep 30, 2024 | 115.41% |
| Jun 30, 2024 | -195.24% |
| Mar 31, 2024 | 20.03% |
| Dec 31, 2023 | 281.76% |
| Sep 30, 2023 | -343.66% |
| Jun 30, 2023 | 50.53% |
| Mar 31, 2023 | 22.47% |
| Dec 31, 2022 | -503.26% |
| Sep 30, 2022 | 77.56% |
| Jun 30, 2022 | 489.81% |
| Mar 31, 2022 | 741.45% |
| Dec 31, 2021 | 1,009.96% |
| Sep 30, 2021 | 88.85% |
| Jun 30, 2021 | 511.93% |